During the past decade, Humanity & Health Research Centre conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Humanity & Health Research Centre" are "Chronic Hepatitis B" (1 trials), "HCV Infection" (1 trials), "Hepatocellular Carcinoma" (1 trials) and "Immune Thrombocytopenia" (1 trials). Many other conditions were trialed in "Humanity & Health Research Centre" in a lesser frequency.

Most popular intervention types in "Humanity & Health Research Centre" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Cabozantinib" (1 trials), "Durvalumab" (1 trials), "Eltrombopag" (1 trials), "Keep current treatment (anti-HBV neucleos(t)ides)" (1 trials) and "Lenvatinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Humanity & Health Research Centre" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Humanity & Health Research Centre". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Humanity & Health Research Centre, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Humanity & Health Research Centre, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".